Thomas Lee

This inventor holds 33 USPTO granted patents and 13 published patent applications, plus 11 CIPO patents and 20 EPO patents. Top assignees: Pepsico, Inc., Concentrate Manufacturing Company of Ireland, Signal Pharmaceuticals, Inc.. Active years: 2006-2025.

USPTO Granted Patents = 33 (Patent Applications = 13)

% Patents Active = 84.8

CIPO Patents = 11 (Patent Applications = 4)

EPO Patents = 20 (Patent Applications = 25)

Average Co-Inventor Count = 3.0

ph-index = 7

Forward Citations = 253(Granted Patents)

Location History:

Hong Kong, CN (2016)
Bedminster, NJ (US) (2015 - 2018)
Scarsdale, NY (US) (2006 - 2023)

Company Filing History:

Concentrate Manufacturing Company of Ireland

patents

4 out of 169

Signal Pharmaceuticals, Inc.

Years Active: 2006-2025

Loading Chart...

Areas of Expertise:

Compositions

Sweetness Enhancers

Pharmaceutical Formulations

Natural Beverage Products

Nanosuspension

Steviol Glycosides

Diet Beverages

Microfluidization Process

Color Stabilizers

Erythritol

D-Tagatose

Oral Dosage Forms

33 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12458045 - Compositions and comestibles (2025-11-04),

2. 11800883 - Compositions and comestibles (2023-10-31),

3. 11700869 - Mouthfeel enhancing composition (2023-07-18),

4. 10966447 - Glucosyringic acid analogs as sweetness profile modifiers (2021-04-06),

5. 10932483 - Sweetness enhancer (2021-03-02),

6. 10052322 - Pharmaceutical formulations, processes, solid forms and methods of use relating to 1-ethyl-7-(2-methyl-6-(1H-1,2,4-triazol-3-yl)pyridin-3-yl)-3,4-dihydropyrazino[2,3-b]pyrazin-2(1H)-one (2018-08-21),

7. 9877500 - Natural beverage products (2018-01-30),

8. 9827243 - Pharmaceutical formulations, processes, solid forms and methods of use relating to 1-ethyl-7-(2-methyl-6-(1H-1,2,4-triazol-3-yl)pyridin-3-yl)-3,4-dihydropyrazino[2,3-b]pyrazin-2(1H)-one (2017-11-28),

9. 9757355 - Oral dosage forms of cyclopropanecarboxylic acid {2-[(1S)-1-(3-ethoxy-4-methoxy-phenyl)-2-methanesulfonyl-ethyl]-3-oxo-2,3-dihydro-1H-isoindol-4-yl}-amide (2017-09-12),

10. 9616019 - Nanosuspension of a poorly soluble drug via microfluidization process (2017-04-11),

11. 9585418 - Method of producing Rebaudioside D sweetened diet carbonated soft drinks (2017-03-07),

12. 9403829 - [object Object] (2016-08-02),

13. 9359364 - Pharmaceutical formulations, processes, solid forms and methods of use relating to 1-ethyl-7-(2-methyl-6-(1H-1,2,4-triazol-3-yl)pyridin-3-yl)-3,4-dihydropyrazino[2,3-b] pyrazin-2(1H)-one (2016-06-07),

14. 9314048 - Beverage products with non-nutritive sweetener and bitterant (2016-04-19),

15. 9023886 - Nanosuspension of a poorly soluble drug via microfluidization process (2015-05-05),

Title: The Innovative Journey of Thomas Lee

Introduction: Thomas Lee, a visionary inventor hailing from Scarsdale, NY, has made significant contributions to the world of technology and innovation through his groundbreaking inventions.

Latest Patents: Thomas Lee's latest patents include a cutting-edge virtual reality device that revolutionizes the gaming industry, a sustainable energy solution that aims to combat climate change, and a medical device that enhances patient care in hospitals worldwide.

Career Highlights: With a career spanning over two decades, Thomas Lee has established himself as a pioneer in the field of technology. His innovative spirit has led to the development of numerous products that have improved the lives of people globally.

Collaborations: Throughout his career, Thomas Lee has collaborated with leading tech companies, research institutions, and universities to bring his inventions to life. His partnerships have been instrumental in pushing the boundaries of innovation and creating products that shape the future.

Conclusion: Thomas Lee's passion for innovation and his relentless pursuit of excellence have cemented his legacy as a trailblazer in the world of technology. His inventions continue to inspire the next generation of inventors and pave the way for a more innovative future.